|
1
|
Croxatto HB: Physiology of gamete and
embryo transport through the fallopian tube. Reprod Biomed Online.
4:160–169. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Latif F, Tory K, Gnarra J, Yao M, Duh FM,
Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al:
Identification of the von Hippel-Lindau disease tumor suppressor
gene. Science. 260:1317–1320. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamada M, Suzuki K, Kato Y, Okuda H and
Shuin T: von Hippel-Lindau protein promotes the assembly of actin
and vinculin and inhibits cell motility. Cancer Res. 61:4184–4189.
2001.PubMed/NCBI
|
|
4
|
Lu N, Hui H, Yang H, Zhao K, Chen Y, You
QD and Guo QL: Gambogic acid inhibits angiogenesis through
inhibiting PHD2-VHL-HIF-1α pathway. Eur J Pharm Sci. 49:220–226.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohh M, Park CW, Ivan M, Hoffman MA, Kim
TY, Huang LE, Pavletich N, Chau V and Kaelin WG: Ubiquitination of
hypoxia-inducible factor requires direct binding to the beta-domain
of the von Hippel-Lindau protein. Nat Cell Biol. 2:423–427. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou MI, Wang H, Foy RL, Ross JJ and Cohen
HT: Tumor suppressor von Hippel-Lindau (VHL) stabilization of
Jade-1 protein occurs through plant homeodomains and is VHL
mutation dependent. Cancer Res. 64:1278–1286. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schraml P, Struckmann K, Hatz F, Sonnet S,
Kully C, Gasser T, Sauter G, Mihatsch MJ and Moch H: VHL mutations
and their correlation with tumour cell proliferation, microvessel
density, and patient prognosis in clear cell renal cell carcinoma.
J Pathol. 196:186–193. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shuin T, Yamasaki I, Tamura K, Okuda H,
Furihata M and Ashida S: Von Hippel-Lindau disease: molecular
pathological basis, clinical criteria, genetic testing, clinical
features of tumors and treatment. Jpn J Clin Oncol. 36:337–343.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rajakumar A, Doty K, Daftary A, Markovic N
and Conrad KP: Expression of von Hippel Lindau (pVHL) protein in
placentae from normal pregnant women and women with preeclampsia.
Placenta. 27:411–421. 2006. View Article : Google Scholar
|
|
10
|
Noyes RW, Hertig AT and Rock J: Dating the
endometrial biopsy. Am J Obstet Gynecol. 122:262–263.
1975.PubMed/NCBI
|
|
11
|
Richards FM, Schofield PN, Fleming S and
Maher ER: Expression of the von Hippel-Lindau disease tumour
suppressor gene during human embryogenesis. Hum Mol Genet.
5:639–644. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang N, Mack F, Haase VH, Simon MC and
Johnson RS: pVHL function is essential for endothelial
extracellular matrix deposition. Mol Cell Biol. 26:2519–2530. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Davidowitz EJ, Schoenfeld AR and Burk RD:
VHL induces renal cell differentiation and growth arrest through
integration of cell-cell and cell-extracellular matrix signaling.
Mol Cell Biol. 21:865–874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schermer B, Ghenoiu C, Bartram M, Müller
RU, Kotsis F, Höhne M, Kühn W, Rapka M, Nitschke R, Zentgraf H, et
al: The von Hippel-Lindau tumor suppressor protein controls
ciliogenesis by orienting microtubule growth. J Cell Biol.
175:547–554. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lyons R, Saridogan E and Djahanbakhch O:
The reproductive significance of human Fallopian tube cilia. Hum
Reprod Update. 12:363–372. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Crow J, Amso NN, Lewin J and Shaw RW:
Morphology and ultrastructure of fallopian tube epithelium at
different stages of the menstrual cycle and menopause. Hum Reprod.
9:2224–2233. 1994.PubMed/NCBI
|
|
17
|
Comer MT, Leese H and Southgate J:
Induction of a differentiated ciliated cell phenotype in primary
cultures of Fallopian tube epithelium. Hum Reprod. 13:3114–3120.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Esteban MA, Harten SK, Tran MG and Maxwell
PH: Formation of primary cilia in the renal epithelium is regulated
by the von Hippel-Lindau tumor suppressor protein. J Am Soc
Nephrol. 17:1801–1806. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lutz MS and Burk RD: Primary cilium
formation requires von hippel-lindau gene function in renal-derived
cells. Cancer Res. 66:6903–6907. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Makrigiannakis A, Karamouti M, Petsas G,
Makris N, Nikas G and Antsaklis A: The expression of receptivity
markers in the fallopian tube epithelium. Histochem Cell Biol.
132:159–167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ohh M, Yauch RL, Lonergan KM, Whaley JM,
Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG Jr and
Iliopoulos O: The von Hippel-Lindau tumor suppressor protein is
required for proper assembly of an extracellular fibronectin
matrix. Mol Cell. 1:959–968. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou Q, Pardo A, Königshoff M, Eickelberg
O, Budinger GR, Thavarajah K, Gottardi CJ, Jones J, Varga J and
Selman M: Role of von Hippel-Lindau protein in fibroblast
proliferation and fibrosis. FASEB J. 25:3032–3044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lonser RR, Glenn GM, Walther M, Chew EY,
Libutti SK, Linehan WM and Oldfield EH: von Hippel-Lindau disease.
Lancet. 361:2059–2067. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sülz L, Valenzuela JP, Salvatierra AM,
Ortiz ME and Croxatto HB: The expression of alpha (v) and beta3
integrin subunits in the normal human Fallopian tube epithelium
suggests the occurrence of a tubal implantation window. Hum Reprod.
13:2916–2920. 1998. View Article : Google Scholar
|
|
25
|
Guo W and Giancotti FG: Integrin
signalling during tumour progression. Nat Rev Mol Cell Biol.
5:816–826. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji Q and Burk RD: Downregulation of
integrins by von Hippel-Lindau (VHL) tumor suppressor protein is
independent of VHL-directed hypoxia-inducible factor alpha
degradation. Biochem Cell Biol. 86:227–234. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Esteban-Barragán MA, Ávila P,
Álvarez-Tejado M, Gutiérrez MD, García-Pardo Á, Sánchez-Madrid F
and Landázuri MO: Role of the von Hippel-Lindau tumor suppressor
gene in the formation of β1-integrin fibrillar adhesions. Cancer
Res. 62:2929–2936. 2002.
|
|
28
|
Mastroianni L Jr: The fallopian tube and
reproductive health. J Pediatr Adolesc Gynecol. 12:121–126. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wanggren K, Lalitkumar P, Stavreus-Evers
A, Stabi B and Gemzell-Danielsson K: Prostaglandin E2 and F2alpha
receptors in the human Fallopian tube before and after mifepristone
treatment. Mol Hum Reprod. 12:577–585. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Semenza GL: Hypoxia-inducible factor 1
(HIF-1) pathway. Sci STKE. 2007:pp. cm82007, View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maxwell PH, Wiesener MS, Chang GW,
Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and
Ratcliffe PJ: The tumour suppressor protein VHL targets
hypoxia-inducible factors for oxygen-dependent proteolysis. Nature.
399:271–275. 1999. View
Article : Google Scholar : PubMed/NCBI
|
